Avancen MOD Corporation is a biotechnology and healthcare startup headquartered in the United States. Established in 2009, the company's slogan "Empowering Patients to Fight Pain" aligns with its mission to enhance direct patient care, comfort, and satisfaction through its groundbreaking product, Medication on Demand (MOD), which is recognized as the world’s first oral PCA. Avancen MOD Corporation aims to deliver lasting value and support to its hospital and healthcare facility customers, as well as the patients they serve. The startup secured Equity Crowdfunding investment in 22 July 2015. The details of the investors related to this round of funding were not provided.
No recent news or press coverage available for Avancen MOD Corporation.